Report

Socio-Economic Value of Adult Immunisation Programmes

This report demonstrates the health and socioeconomic value of adult immunisation programmes against seasonal influenza (influenza), pneumococcal disease (PD), herpes zoster (HZ), and respiratory syncytial virus (RSV) in ten countries (Australia, Brazil, France, Germany, Italy, Japan, Poland, South Africa, Thailand, and the United States of America).

Languages

  • English

Publication year

2024

Type

Report

Categories

  • Data

Diseases

  • Influenza
  • Pneumococcal disease

Countries

  • Australia
  • Brazil
  • France
  • Germany
  • Italy
  • Japan
  • Poland
  • South Africa
  • Thailand
  • United States of America

ADULT-REPORTS

TitleAuthorYearTypeLanguage
Socio-Economic Value of Adult Immunisation ProgrammesHania El Banhawi, Sulayman Chowdhury, Margherita Neri, Priscila Radu, Sian Hodgson, Eleanor Bell, Simon Brassel, Lotte Steuten2024ReportEnglish
Global Status of Adult Immunization Post COVID-19 PandemicAlba Vilajeliu, Victor Vega, Randie Gibson, Francisco Nogareda, Xiaojun Wang, Donald J Brooks, Charles Shey Wiysonge, Osman Niyazi Cakmak, Osama Mere, Melanie Marti, Philipp Lambach, Stephanie Shendale, Marcela Contreras, Emmanuel Njambe, Erin Grace Sparrow, Joachim Hombach, Ann Lindstrand2025Journal articleEnglish
Global Atlas on Adult Vaccination (GAAV)Vaccines4Life2025ToolEnglish
Adult Immunization BoardAdult Immunization Board (AIB)2023RepositoryEnglish